Devin Oglesbee

Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators

George T. Hanson, Robert Aggeler, Devin Oglesbee et al. · Journal of Biological Chemistry · 2004 · 995 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 352 citations · Full text

Medicine, Biochemistry, Mass Spectrometric Analysis +16

Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: The Mayo Clinic experience (2004–2007)

Dietrich Matern, Silvia Tortorelli, Devin Oglesbee et al. · Journal of Inherited Metabolic Disease · 2007 · 222 citations · Full text

Medicine, Pediatrics, Preventive Medicine +12

Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity

Rohit Sharma, Bryn Reinstadler, Kristin Engelstad et al. · Journal of Clinical Investigation · 2021 · 199 citations · Full text

Life Sciences, Biochemistry, Molecular Genetics +17

Combined Newborn Screening for Succinylacetone, Amino Acids, and Acylcarnitines in Dried Blood Spots

Coleman Turgeon, Mark J Magera, Pierre Allard et al. · Clinical Chemistry · 2008 · 142 citations · Full text

Natural Sciences, Biochemistry, Analytical Chemistry +16